BridgeBio Oncology Therapeutics Inc. (BBOT)
NASDAQ: BBOTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.44 0.00%
BBOT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $275.80M
- EPS (TTM)
- -$0.07
- Dividend yield
- None
- 52-week range
- 3.36 – 14.87
- Day range
- 3.36 – 3.57
- Volume / Avg
- 321.31K / 475.11K
- Beta
- —
- Shares outstanding
- 80.17M
- Next earnings
- Nov 11, 2026
52-week range
BBOT stock today
On Oct 7, BBOT ended the session at $3.44, shedding $0.06 (1.71%), versus the S&P 500's 0.22% decline. Shares are 76.9% below their 52-week high of $14.87, set on Dec 8, 2025 and 2.4% above the 52-week low of $3.36, near the bottom of the past year's range. BBOT is down 72.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 71.8%.
BridgeBio Oncology Therapeutics has posted a net loss over the last twelve months (EPS of -$0.07), so its P/E ratio is not meaningful. BridgeBio Oncology Therapeutics's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About BridgeBio Oncology Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 11, 2026
BridgeBio Oncology Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CATXPerspective Therapeutics Inc. | 2.46 | +4.24% | $280.81M | vs BBOT |
| FULCFulcrum Therapeutics Inc. | 3.67 | -0.54% | $280.01M | vs BBOT |
| RCKTRocket Pharmaceuticals Inc. | 2.54 | +2.22% | $278.28M | vs BBOT |
| VNDAVanda Pharmaceuticals Inc. | 4.56 | +0.89% | $275.71M | vs BBOT |
| LRMRLarimar Therapeutics Inc. | 2.75 | -1.08% | $285.68M | vs BBOT |
| BIOABioAge Labs Inc. | 6.26 | -0.48% | $287.31M | vs BBOT |
| ABEOAbeona Therapeutics Inc. | 5.08 | +1.40% | $290.49M | vs BBOT |
| BCYCBicycle Therapeutics plc ADR | 3.73 | -1.58% | $261.07M | vs BBOT |
Indexes, lists and sector
BridgeBio Oncology Therapeutics stock FAQ
What is BridgeBio Oncology Therapeutics's stock price today?
BBOT last traded at $3.44 as of Oct 7, 4:00 PM EDT, down 1.71% on the day. Prices are delayed at least 15 minutes.
When is BridgeBio Oncology Therapeutics's next earnings date?
BridgeBio Oncology Therapeutics is expected to report earnings on Wednesday, November 11, 2026.
What is the BBOT 52-week high?
The 52-week high for BBOT is $14.87 and the 52-week low is $3.36. The stock is currently 76.9% below its high.